Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
作者信息
Arias-Santiago S, Camacho-Martínez F M
机构信息
Unidad de Gestión Clínica de Dermatología, Complejo Hospitalario Universitario de Granada, Granada, España.
Catedrático de Dermatología, Universidad de Sevilla, España; Presidente de Honor de la Academia Española de Dermatología.
出版信息
Actas Dermosifiliogr. 2016 Nov;107(9):709-711. doi: 10.1016/j.ad.2016.06.006. Epub 2016 Jul 18.
PMID:27436801
Abstract
摘要
相似文献
1
Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
Actas Dermosifiliogr. 2016 Nov;107(9):709-711. doi: 10.1016/j.ad.2016.06.006. Epub 2016 Jul 18.
2
[Finasteride adverse effects: An update].
Rev Med Chil. 2016 Dec;144(12):1584-1590. doi: 10.4067/S0034-98872016001200010.
3
Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
Sex Med Rev. 2019 Apr;7(2):277-282. doi: 10.1016/j.sxmr.2018.07.003. Epub 2018 Oct 6.
4
Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
Dermatol Online J. 2017 Nov 11;23(11):13030/qt24k8q743.
5
The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
Curr Urol Rep. 2018 Jun 16;19(8):65. doi: 10.1007/s11934-018-0814-z.
6
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Acta Derm Venereol. 2019 Jan 1;99(1):12-17. doi: 10.2340/00015555-3035.
7
5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study.
J Am Acad Dermatol. 2021 Jan;84(1):172-173. doi: 10.1016/j.jaad.2020.04.051. Epub 2020 Apr 19.
8
Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
Andrology. 2017 Jul;5(4):671-678. doi: 10.1111/andr.12353. Epub 2017 Apr 28.
9
Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: A global propensity score matched retrospective cohort study.
J Am Acad Dermatol. 2024 Jul;91(1):163-166. doi: 10.1016/j.jaad.2024.03.019. Epub 2024 Mar 28.
10
Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs.
Arch Ital Urol Androl. 2016 Jan 14;87(4):312-6. doi: 10.4081/aiua.2015.4.312.
引用本文的文献
1
Study on the Efficacy and Potential Mechanism of Topical Shen Bai Hair Growing Decoction against Androgenetic Alopecia Based on Ultrahigh Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry and RNA-seq.
ACS Omega. 2024 Feb 26;9(9):10834-10851. doi: 10.1021/acsomega.3c09648. eCollection 2024 Mar 5.
2
Pharmacological Management of Pattern Hair Loss.
Indian J Plast Surg. 2021 Dec 13;54(4):422-434. doi: 10.1055/s-0041-1739254. eCollection 2021 Oct.
3
Post-finasteride syndrome.
An Bras Dermatol. 2020 May-Jun;95(3):271-277. doi: 10.1016/j.abd.2020.02.001. Epub 2020 Mar 25.
Zotero 插件